60MO Ovarian function in young patients (pts) treated with postneoadjuvant palbociclib (PAL) and endocrine therapy (ET) for hormone receptor (HR)-positive, HER2-negative early breast cancer (BC): Explorative analysis in Penelope-B
Titel:
60MO Ovarian function in young patients (pts) treated with postneoadjuvant palbociclib (PAL) and endocrine therapy (ET) for hormone receptor (HR)-positive, HER2-negative early breast cancer (BC): Explorative analysis in Penelope-B
Auteur:
Furlanetto, J. Marmé, F. Thode, C. Nekljudova, V. Liu, Y. Martin Jimenez, M. Reimer, T. Knudsen, E. Denkert, C. Bassy, M. Martin, L-A. Karn, T. Sinn, B.V. Filipitis, M. van Mackelenbergh, M. Fasching, P.A. Müller, V. Stickeler, E. Schem, C. Loibl, S.